We are excited to be named to the @DigitalHealthNY 100, joining the ranks of past winners @capsule_health , @mavenclinic , @OscarHealth, @ro , @swordhealth , @Talkiatry , @talkspace and @Zocdoc. Read more in today's press release:

Proud to powering Screening Central,@SanofiUS first #telehealth-enabled, user-initiated #T1D autoantibody screening platform, now available across the U.S. Expanding access to early screening means more #proactivehealth and better #healthoutcomes.

RT @pearvc: We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma progr…

RT @pejmannozad: We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma…

Today at #HLTHUSA, we announced the availability of a Complete Blood Count (CBC) test with at-home sample collection for direct-to-patient (DTP) biopharma programs. Routine CBC tests is used for asthma, heart disease, and kidney disease. #HLTHUSA2024 #hlth

We’re pleased to announce the launch of ixEngage, our direct-to-patient solution for biopharma that builds on our groundbreaking digital platform that has powered 1,110+ nationwide programs and over 4 million patient care journeys:

Attending #DPE24? Don’t miss out on our panel discussion, “Leveraging Technology to Improve the Patient Experience and Drive Better Outcomes” featuring insights marketers from @sanofi , @AstraZeneca, @CSLBehring. #DigitalPharmaEast #FiercePharma #DigitalPharma #PharmaMarketing

ixlayer direct-to-patient platform allows biopharma organizations to quickly launch an optimized patient Cx with transparency and control. Our configurable platform enables us to build distinct programs for multiple therapeutic areas within biopharma ecosystem.

NEW IXLAYER PHYSICIAN SURVEY REVEALS OVERWHELMING SUPPORT FOR AT-HOME DIAGNOSTIC TESTING:

HCPs show cautious support for at-home diagnostic testing

Doctors support growth of at-home testing, survey finds, opening new avenues for biopharma patient outreach

RT @MPOmagazine: New @ixlayer_ survey shows a large support of at-home diagnostic testing:

RT @DigitalPharma: 🎉We are thrilled to announce @ixlayer_ as a proud partner for #DPEAST 2024! Get tickets to Digital Pharma East here: htt…

We’re pleased to announce the expansion to our Clinical Advisory Board with the addition of Kevin Ban, MD, Chief Medical Officer with Walgreens. Dr Ban brings over 25 years of clinical and administrative experience. Read more:

We’re excited to announce the launch of our new data visualization solution that empowers healthcare organizations to harness real-time data for actionable insights to improve outcomes across the healthcare ecosystem. Read more:

See you in a couple days at #HLTH2023? Find out why ixlayer’s cloud-based platform is an industry leader for diagnostic health testing. Stop by our booth 3427 or schedule a meeting today:

We are excited to announce the launch of our newly designed website! Our new site provides you with greater access to who we are, the markets we serve and our competitive differentiation. Check it out now:

Did you know, there are over 55 million people in the world living with dementia? It’s never too early or too late to take action to reduce the risk of developing dementia. #WorldAlzheimersMonth

Join us this Wednesday, September 27, alongside experts from @Biosprings, @Ginkgo, @LabvivaNews, and @Path_AI to discuss their experience navigating #biopharma deals. Register for webinar:

High blood cholesterol typically has no signs or symptoms but can lead to heart attacks and strokes. That’s why it’s important to have your cholesterol checked by your doctor. All it takes is a simple blood test. #CholesterolEducationMonth